These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 565811)

  • 1. [The molecular structure of N-hydroxymethylpyrrolidone carboxylic acid. The structure determination of the reaction product of L-pyroglutamic acid with formaldehyde (author's transl)].
    Kanao S; Nagashima N
    Yakugaku Zasshi; 1978 Mar; 98(3):293-6. PubMed ID: 565811
    [No Abstract]   [Full Text] [Related]  

  • 2. Conformational properties of 2,3-methanopyroglutamic acid in peptides: NMR and x-ray diffraction studies.
    Mapelli C; Elrod LF; Switzer FL; Stammer CH; Holt EM
    Biopolymers; 1989 Jan; 28(1):123-8. PubMed ID: 2497811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [On the ring substituted 1-acrylpyrrolidine- and 1-acyl-2-pyrroline-4-carboxylic acids and their anti-inflammatory activity].
    Kejha J; Nĕmecek O; Grimová J; Kakác B
    Cesk Farm; 1976 Sep; 25(7):258-65. PubMed ID: 991286
    [No Abstract]   [Full Text] [Related]  

  • 4. [Synthesis and pharmacological activity of some carboxy pyrrolidinones and several derivatives (author's transl)].
    Robert J; Boucherle A
    Ann Pharm Fr; 1981; 39(4):337-46. PubMed ID: 7305244
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis of a series of residue 1 (pyroglutamic acid) analogs of thyrotrophin releasing hormone.
    Bauce LG; Goren HJ
    Int J Pept Protein Res; 1979; 14(3):216-26. PubMed ID: 118133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrrolidinones derived from (S)-pyroglutamic acid: penmacric acid and analogues.
    Anwar M; Bailey JH; Dickinson LC; Edwards HJ; Goswami R; Moloney MG
    Org Biomol Chem; 2003 Jul; 1(13):2364-76. PubMed ID: 12945710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The crystal structure of 3-hydroxy-3-isobutyl-2-pyrrolidone-5-carboxylic acid, lactam of 4-hydroxy-4-isobutylglutamic acid from Reseda odorata L.
    Kaas K; Sorensen H
    Acta Chem Scand A; 1977; 31(5):364-8. PubMed ID: 883458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of cis-4-trifluoromethyl- and cis-4-difluoromethyl-l-pyroglutamic acids.
    Qiu XL; Qing FL
    J Org Chem; 2003 May; 68(9):3614-7. PubMed ID: 12713369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemico-pharmaceutical and pharmacodynamic characteristics of pyrglutargine].
    Selleri R; Orzalesi G; Innocenti F; Volpato I; Bisagno T
    Boll Chim Farm; 1977 Dec; 116(12):735-43. PubMed ID: 610732
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and angiotensin-converting enzyme inhibitory activity of 3-(Mercaptomethyl)-2-oxo-1-pyrrolidineacetic acids and 3-(Mercaptomethyl)-2-oxo-1-piperidineacetic acids.
    Klutchko S; Hoefle ML; Smith RD; Essenburg AD; Parker RB; Nemeth VL; Ryan MJ; Dugan DH; Kaplan HR
    J Med Chem; 1981 Jan; 24(1):104-9. PubMed ID: 6259352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weak acid-catalyzed pyrrolidone carboxylic acid formation from glutamine during solid phase peptide synthesis. Minimization by rapid coupling.
    Dimarchi RD; Tam JP; Kent SB; Merrifield RB
    Int J Pept Protein Res; 1982 Jan; 19(1):88-93. PubMed ID: 7118385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Michael addition with acylamino acid esters II. -Preparation of 3-aryl-2,4-bis(ethoxycarbonyl)-2-methyl-5-pyrrolidones (author's transl)].
    Pachaly P; Westfeld HP
    Arch Pharm (Weinheim); 1977 Apr; 26(4):334-7. PubMed ID: 860903
    [No Abstract]   [Full Text] [Related]  

  • 13. Rational design of highly diastereoselective, organic base-catalyzed, room-temperature Michael addition reactions.
    Soloshonok VA; Cai C; Hruby VJ; Van Meervelt L; Yamazaki T
    J Org Chem; 2000 Oct; 65(20):6688-96. PubMed ID: 11052120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FR-900148, a new antibiotic. II. Structure determination of FR-900148.
    Kuroda Y; Okuhara M; Goto T; Okamoto M; Yamashita M; Kohsaka M; Aoki H; Imanaka H
    J Antibiot (Tokyo); 1980 Mar; 33(3):267-71. PubMed ID: 7380738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A family with pyroglutamic aciduria (author's transl)].
    Porath U; Schreier K
    Dtsch Med Wochenschr; 1978 Jun; 103(22):939-42. PubMed ID: 657978
    [No Abstract]   [Full Text] [Related]  

  • 16. From N-triisopropylsilylpyrrole to an optically active C-4 substituted pyroglutamic acid: total synthesis of penmacric acid.
    Berini C; Pelloux-Léon N; Minassian F; Denis JN
    Org Biomol Chem; 2009 Nov; 7(21):4512-6. PubMed ID: 19830303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthesis of pyrrolidonecarboxylic acid (PCA). Report].
    Jacórzyński B
    Rocz Panstw Zakl Hig; 1972; 23(1):73-5. PubMed ID: 5031465
    [No Abstract]   [Full Text] [Related]  

  • 18. [Conformation analysis of L-pyroglutamic acid N-methylamide by depolarized Rayleigh diffusion, vibration spectroscopy, and conformational energy calculation].
    Allard M; Avignon M; Bellocq AM
    Biopolymers; 1975 Aug; 14(8):1569-79. PubMed ID: 1156655
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of chirality on the structural behaviour of hydrogen-bonded n-alkylammonium pyroglutamates in the crystalline and smectic state.
    Tsiourvas D; Paleos CM; Skoulios A
    Chemistry; 2003 Nov; 9(21):5250-8. PubMed ID: 14613133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of ( 2S, 4S)-4-phenylamino-5-oxoproline derivatives.
    Nizova IA; Krasnov VP; Levit GL; Kodess MI
    Amino Acids; 2002; 22(2):179-86. PubMed ID: 12395185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.